{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:53:56Z","timestamp":1771649636547,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cji.0b013e3181ab1807","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T07:24:09Z","timestamp":1247815449000},"page":"755-764","source":"Crossref","is-referenced-by-count":43,"title":["HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor"],"prefix":"10.1097","volume":"32","author":[{"given":"Mikael","family":"Sundin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Uzunel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"L\u00f6nnies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa-Lena","family":"Dackland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birger","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina Le","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"Togel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell energy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"Ringden","year":"2007","journal-title":"Leukemia"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J Biomed Sci"},{"key":"R11-8-20210227","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"R12-8-20210227","first-page":"469","article-title":"Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens","volume":"41","author":"Angoulvant","year":"2004","journal-title":"Biorheology"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1189\/jlb.0307140","article-title":"Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.","volume":"82","author":"Rasmusson","year":"2007","journal-title":"JLeukoc Biol"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.0401558101","article-title":"Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion","volume":"101","author":"Pochampally","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-8-20210227","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","article-title":"Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates","volume":"101","author":"Devine","year":"2003","journal-title":"Blood"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.0000070931.62772.4E","article-title":"In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction","volume":"107","author":"Kraitchman","year":"2003","journal-title":"Circulation"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/81395","article-title":"Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep","volume":"6","author":"Liechty","year":"2000","journal-title":"Nat Med"},{"key":"R18-8-20210227","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000124222.16321.26","article-title":"Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart","volume":"109","author":"Airey","year":"2004","journal-title":"Circulation"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2007.12.011","article-title":"A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases","volume":"30","author":"Ikehara","year":"2008","journal-title":"J Autoimmun"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.leu.2402786","article-title":"Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma","volume":"17","author":"Fouillard","year":"2003","journal-title":"Leukemia"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"R23-8-20210227","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringden","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group","volume":"83","author":"Ringden","year":"1994","journal-title":"Blood"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials","volume":"71","author":"Storb","year":"1988","journal-title":"Blood"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematologica"},{"key":"R27-8-20210227","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation"},{"key":"R29-8-20210227","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"key":"R30-8-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"R31-8-20210227","first-page":"583","article-title":"Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens","volume":"19","author":"Moller","year":"1970","journal-title":"Immunology"},{"key":"R32-8-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","author":"Le Blanc","year":"2004","journal-title":"Scand J Immunol"},{"key":"R33-8-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1704296","article-title":"Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation","volume":"33","author":"Uzunel","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R34-8-20210227","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-8-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"R36-8-20210227","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jtcvs.2003.07.037","article-title":"Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium","volume":"127","author":"Grinnemo","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R37-8-20210227","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3727\/000000006783981503","article-title":"Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons","volume":"15","author":"Beggs","year":"2006","journal-title":"Cell Transplant"},{"key":"R38-8-20210227","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"R39-8-20210227","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"key":"R40-8-20210227","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"R41-8-20210227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexcr.2004.12.013","article-title":"Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms","volume":"305","author":"Rasmusson","year":"2005","journal-title":"Exp Cell Res"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e3181ab1807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:03:47Z","timestamp":1621886627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200909000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181ab1807","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}